- $39.30m
- $127.14m
- $182.60m
- 59
- 86
- 54
- 73
Annual balance sheet for Zepp Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 20-F | 20-F | 20-F | 6-K | 6-K |
Standards: | USG | USG | USG | — | — |
Status: | fx Final | fx Final | fx Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 352 | 235 | 134 | 139 | 92.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 196 | 171 | 126 | 69.3 | 65.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 740 | 619 | 429 | 317 | 252 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 42.3 | 38.1 | 24.1 | 15.7 | 10.4 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 905 | 958 | 764 | 636 | 529 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 428 | 339 | 242 | 155 | 195 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 486 | 498 | 376 | 285 | 277 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 418 | 460 | 387 | 351 | 252 |
Total Liabilities & Shareholders' Equity | 905 | 958 | 764 | 636 | 529 |
Total Common Shares Outstanding |